Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus

Yonsei Medical Journal

Volumn 46, Issue 1, 2005, Pages 42-50

  Kim, Mi Jin ^a   Yoo, Kwang Ha ^a   Park, Hyung Suk ^a   Chung, Sang Man ^a   Jin, Choon Jo ^a   Lee, Yoen ^b   Shin, Young Goo ^b   Chung, Choon Hee ^b  

^a Konkuk University   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

Adiponectin; Diabetes mellitus; Insulin resistance

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ANALYZER; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; DIET RESTRICTION; FASTING BLOOD GLUCOSE; FEMALE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; KOREA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 14944373553     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.1.42     Document Type: Article

References (39)

1. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996;2:800-2.
2. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996;87:377-89.
3. Christian W, Tohru F, Sachiyo T, Kikuko H, Yuji M, Richard E, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86: 1930-5.
4. Wei-shiung Y, Yuji M, Chi-Yuan J, Jao-Ping W, Ta-Jen W, Chi-Ling C, et al. Synthetic peroxisome proliferator activated receptor- α agonist, rosiglitazone, increase plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 2002;25:376-80.
5. Ouchi N, Kihara S, Arita Y, Maeda Kuriyama H, Okamoto Y, Hotta Nishida M, et al. Novel modulator for endothelial adhesion molecules: adipocyte derived plasma protein adiponectin. Circulation 1999;100:2473-6.
6. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
7. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a newel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Throm Vasc Biol 2000;20:1595-9.
8. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6.
9. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway. Circulation 2000;102:1296-301.
10. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85:2402-10.
11. Kim EJ, Min HK, Choi YK, Huh KB, Shin SH. Diabetes. 2th ed. Korean Diabetes Association: Korea medical publishing co; 1998.
12. Hotamisligil GS, Spiegelman BM. Tumor-necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-8.
13. Hotamisligil GS, Murray DL, Choy LS, Spiegelman BM. Tumor necrosis factor- α inhibits signaling from the insulin receptor. Proc Natl Acad Sci 1994;91:4854-8.
14. Alwssi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible line between visceral fat accumulation and vascular disease. Diabetes 1997;46:860-7.
15. Yudkin JS, Kumari M, Humphries SE, Mohammed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148:209-14.
16. 3, but not acylation-stimulating protein concentration. Diabetes Care 2000;23:779-85.
17. Maeda K, Okubo K, Ahimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 1996;221:286-9.
18. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-9.
19. Hu E, Liang P, Spiegelman BM. Adipo Q is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;18:10697-703.
20. Takahashi M, Arita Y, Yamagata K, Matsukawa Y, Okutomi K, Horie M, et al. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord 2000;24:861-8.
21. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 1998; 12:335-8.
22. Yokota T, Oritani K, Takahashi I, Ishikana J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the function of macrophages. Blood 2000;96:1723-32.
23. Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, et al. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res 2000;1:81-8.
24. Fruebis J, Taso TS, Javorschi S, Ebbets-Reet D, Erickson MR, Yen FT, et al. Proteolytic cleavage product of 30 kd adipocyte complement-related protein increase fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci 2001;98:2005-10.
25. Berg AH, Combs TP, Du X, Brownlee M, Scherer P. The adipocyte-secreted protein Acrp 30 enhances hepatic insulin action. Nat Med 2001;7:947-53.
26. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-9.
27. Nishizawa T, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte derived protein. Diabetes 2002;51:2734-41.
28. DeFronzo RA, Tobin JD, Andres R. The glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
29. Akinmokun A, Selby PL, Ramaiya K, Alberti KGMN. The short insulin tolerance test for the determination of insulin sensitivity: A comparison with the euglycemic clamp. Diabet Med 1992;9:432-7.
30. Hirst S, Phillips DIW, Vines SK, Clark PM, Hales CN. Reproducibility of the short insulin tolerance test. Diabet Med 1993;10:839-42.
31. Grulet H, Durlach V, Hecart AC, Gross A, Leutenegger M. Study of the rate of early glucose disappearance following insulin injection: insulin sensitivity index. Diabetes Res Clin Pract 1993;20:201-7.
32. SW Park, YS Yun, CW Ahn, SH Kwon, JH Nam, SH Han, et al. Short insulin tolerance test (SITT) for the determination of in vivo insulin sensitivity- a comparison with euglycemic clamp test. J Korean Diabetes a Assoc 1999;22:199-208.
33. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recent suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002;156:1070-7.
34. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5.
35. Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004;63:135-42.
36. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003;52:1274-8.
37. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003;16:72-5.
38. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, et al. Adiponectin in essential hypertension. J Nephrol 2002;15:507-11.
39. Matsubara M, Maruka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentration in normal-weight and obese women. Eur J Endocrinol 2002;147:173-80.